Split-thickness autografts still are the current gold standard to treat skin, upon severe injuries. Nonetheless, autografts are dependent on donor site availability and often associated to poor quality neoskin. The generation of dermal–epidermal substitutes by tissue engineering is seen as a promising strategy to overcome this problematic. However, solutions that can be safely and conveniently transplanted in o...
Cases of massive skin loss upon injury or disease still represent a serious healthcare challenge worldwide, and despite the many alternatives available, results are not yet satisfactory. Skin Tissue Engineering, especially now combined with Stem Cell Research, holds great expectation towards an efficient and high quality skin regeneration. Human embryonic stem cells (hESCs) are quite attractive for this purpose...
2008
2007
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |